InvestorsHub Logo
icon url

Lemoncat

04/15/21 12:48 PM

#355779 RE: Jhawker #355772

A combo cocktail with Kevetrin would be great. They can have it for the low low price of $800M. That's only one month of Keytruda revenues.

Then we can run all the Brilacidin trials we want. Fingers crossed.

Go IPIX!